|
| 36268860 | The Chemical Probes Portal: an expert review-based public resource to empower chemical probe assessment, selection and use. | Nucleic Acids Res | 2023 |
| 37602223 | SwarmDeepSurv: swarm intelligence advances deep survival network for prognostic radiomics signatures in four solid cancers. | Patterns (N Y) | 2023 |
| 36624665 | canSAR: update to the cancer translational research and drug discovery knowledgebase. | Nucleic Acids Res | 2023 |
| 35643512 | canSAR chemistry registration and standardization pipeline. | J Cheminform | 2022 |
| 33300337 | Tuning Local Hydration Enables a Deeper Understanding of Protein-Ligand Binding: The PP1-Src Kinase Case. | J Phys Chem Lett | 2021 |
| 33822745 | JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate Cancer. | Cancer Res | 2021 |
| 35211674 | Target 2035 - update on the quest for a probe for every protein. | RSC Med Chem | 2021 |
| 34077750 | Evolution of kinase polypharmacology across HSP90 drug discovery. | Cell Chem Biol | 2021 |
| 31778323 | Public resources for chemical probes: the journey so far and the road ahead. | Future Med Chem | 2021 |
| 33219674 | canSAR: update to the cancer translational research and drug discovery knowledgebase. | Nucleic Acids Res | 2021 |
| 32994435 | Solution structure of the Hop TPR2A domain and investigation of target druggability by NMR, biochemical and in silico approaches. | Sci Rep | 2020 |
| 32066817 | The kinase polypharmacology landscape of clinical PARP inhibitors. | Sci Rep | 2020 |
| 32094403 | Correction: Signalling involving MET and FAK supports cell division independent of the activity of the cell cycle-regulating CDK4/6 kinases. | Oncogene | 2020 |
| 30496479 | canSAR: update to the cancer translational research and drug discovery knowledgebase. | Nucleic Acids Res | 2019 |
| 31296956 | Signalling involving MET and FAK supports cell division independent of the activity of the cell cycle-regulating CDK4/6 kinases. | Oncogene | 2019 |
| 31262731 | Differences in Signaling Patterns on PI3K Inhibition Reveal Context Specificity in <i>KRAS</i>-Mutant Cancers. | Mol Cancer Ther | 2019 |
| 31543384 | A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations. | Eur J Cancer | 2019 |
| 31284790 | Transforming cancer drug discovery with Big Data and AI. | Expert Opin Drug Discov | 2019 |
| 29249694 | Objective, Quantitative, Data-Driven Assessment of Chemical Probes. | Cell Chem Biol | 2018 |
| 30226926 | Genomics, bio specimens, and other biological data: Current status and future directions. | Med Phys | 2018 |
| 30652614 | Leveraging Human Genetics to Guide Cancer Drug Development. | JCO Clin Cancer Inform | 2018 |
| 29662167 | Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets. | Nat Genet | 2018 |
| 27910877 | A comprehensive map of molecular drug targets. | Nat Rev Drug Discov | 2017 |
| 28436422 | Rational design of non-resistant targeted cancer therapies. | Sci Rep | 2017 |
| 28826504 | Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer. | Elife | 2017 |
| 28545060 | SiGNet: A signaling network data simulator to enable signaling network inference. | PLoS One | 2017 |
| 26947069 | Large-Scale Profiling of Kinase Dependencies in Cancer Cell Lines. | Cell Rep | 2016 |
| 26673713 | canSAR: an updated cancer research and drug discovery knowledgebase. | Nucleic Acids Res | 2016 |
| 27669965 | Polypharmacology in Precision Oncology: Current Applications and Future Prospects. | Curr Pharm Des | 2016 |
| 27580970 | Minimizing bias in target selection by exploiting multidisciplinary Big Data and the protein interactome. | Future Med Chem | 2016 |
| 27444228 | Drug discovery in advanced prostate cancer: translating biology into therapy. | Nat Rev Drug Discov | 2016 |
| 26820296 | Blocking the survival of the nastiest by HSP90 inhibition. | Oncotarget | 2016 |
| 25709118 | Therapeutic opportunities within the DNA damage response. | Nat Rev Cancer | 2015 |
| 26699810 | Distinctive Behaviors of Druggable Proteins in Cellular Networks. | PLoS Comput Biol | 2015 |
| 23435416 | JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells. | Oncogene | 2014 |
| 24304894 | canSAR: updated cancer research and drug discovery knowledgebase. | Nucleic Acids Res | 2014 |
| 23361103 | Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance. | Clin Pharmacol Ther | 2013 |
| 24287764 | Drugging cancer genomes. | Nat Rev Drug Discov | 2013 |
| 23810823 | Genome-based cancer therapeutics: targets, kinase drug resistance and future strategies for precision oncology. | Curr Opin Pharmacol | 2013 |
| 23582742 | A novel serum protein signature associated with resistance to epidermal growth factor receptor tyrosine kinase inhibitors in head and neck squamous cell carcinoma. | Eur J Cancer | 2013 |
| 23274470 | Objective assessment of cancer genes for drug discovery. | Nat Rev Drug Discov | 2013 |
| 23319765 | Unpicking the combination lock for mutant BRAF and RAS melanomas. | Cancer Discov | 2013 |
| 21948594 | ChEMBL: a large-scale bioactivity database for drug discovery. | Nucleic Acids Res | 2012 |
| 22781697 | Combinatorial drug therapy for cancer in the post-genomic era. | Nat Biotechnol | 2012 |
| 22516256 | Personalized medicine: patient-predictive panel power. | Cancer Cell | 2012 |
| 22013161 | canSAR: an integrated cancer public translational research and drug discovery resource. | Nucleic Acids Res | 2012 |
| 21632985 | A HIF-regulated VHL-PTP1B-Src signaling axis identifies a therapeutic target in renal cell carcinoma. | Sci Transl Med | 2011 |
| 21936816 | Collation and data-mining of literature bioactivity data for drug discovery. | Biochem Soc Trans | 2011 |
| 21878981 | Minimum information about a bioactive entity (MIABE). | Nat Rev Drug Discov | 2011 |
| 20727982 | Ligand efficiency indices for an effective mapping of chemico-biological space: the concept of an atlas-like representation. | Drug Discov Today | 2010 |